Notes
Funding for the study was provided by Novo Nordisk A/S, Denmark, to the Swedish Institute for Health Economics, Lund, Sweden.
Reference
Andersson E, et al. Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden. Diabetologia : 24 Sep 2020. Available from: URL: http://doi.org/10.1007/s00125-020-05277-3
Rights and permissions
About this article
Cite this article
Burden of type 2 diabetes complications substantial in Sweden. PharmacoEcon Outcomes News 863, 6 (2020). https://doi.org/10.1007/s40274-020-7160-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7160-3